Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?

被引：1
|
作者：
Erridge, Simon [1 ,2 ]
Sodergren, Mikael H. [1 ,2 ,3 ]
机构：
[1] Imperial Coll London, Imperial Coll Med Cannabis Res Grp, Dept Surg & Canc, London, England
[2] Sapphire Med Clin, London, England
[3] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit,Med Cannabis Res Grp, 10th Floor QEQM,South Wharf Rd, London W2 1NY, England
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷 / 02期
关键词：
D O I：
10.1093/ibd/izad221
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [31] The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease
    Roshanov, Pavel S.
    Khanna, Reena
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (01) : 156 - 158
  • [32] Developing a checklist to assess clinical severity indices in inflammatory bowel disease
    Alrubaiy, Laith
    Hutchings, Hayley
    Williams, John
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 159 - 159
  • [33] How to Check the Validity of Clinical Severity Indices in Inflammatory Bowel Disease
    Alrubaiy, Laith
    Williams, John
    Hutchings, Hayley
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S29 - S29
  • [34] DEVELOPING SWANSEA INFLAMMATORY BOWEL DISEASE CLINICAL SEVERITY INDEX (SICSI)
    Alrubaiy, L.
    Williams, J.
    Hutchings, H.
    GUT, 2012, 61 : A225 - A225
  • [35] Developing swansea inflammatory bowel disease clinical severity index (SICSI)
    Alrubaiy, Laith
    Williams, John
    Hutchings, Hayley
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 174 - 174
  • [36] Resistin is an inflammatory marker of inflammatory bowel disease in humans
    Konrad, Astrid
    Lehrke, Michael
    Schachinger, Veronika
    Seibold, Frank
    Stark, Renee
    Ochsenkuehn, Thomas
    Parhofer, Klaus G.
    Goeke, Burkhard
    Broedl, Uli C.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (12) : 1070 - 1074
  • [37] ASSOCIATION BETWEEN USE OF ANTIHYPERTENSIVE AGENTS AND DISEASE SEVERITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Mantaka, Aikaterini
    Tsoukali, Emmanouela
    Fragaki, Maria
    Karmiris, Konstantinos
    Viazis, Nikos
    Mantzaris, Gerassimos J.
    Koutroubakis, Ioannis E.
    GASTROENTEROLOGY, 2019, 156 (06) : S405 - S405
  • [38] Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease
    Mantaka, A.
    Tsoukali, E.
    Fragaki, M.
    Karmiris, K.
    Viazis, N.
    Mantzaris, G.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S497 - S497
  • [39] Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease
    Benson, Melissa J.
    Abelev, Sarah, V
    Corte, Crispin J.
    Connor, Susan J.
    McGregor, Iain S.
    CROHNS & COLITIS 360, 2020, 2 (02)
  • [40] Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey
    Neufeld, Tanja
    Pfuhlmann, Katrin
    Stock-Schroer, Beate
    Kairey, Lana
    Bauer, Nina
    Haeuser, Winfried
    Langhorst, Jost
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (10): : 1068 - 1077
12345